Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03834493 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641) |
| First Submitted : | February 6, 2019 |
| First Submitted that Met QC Criteria : | February 6, 2019 |
| First Posted : | February 8, 2019 |
| Last Update Submitted that Met QC Criteria : | November 22, 2022 |
| Last Update Posted : | November 23, 2022 |